The only way we will find a cure for Parkinson’s disease (PD) is through research. Your participation in research is critical to finding new treatments and improving life for the 10 million people living with Parkinson’s around the world.
Explore the different opportunities to get involved with Parkinson’s research.
PD GENEration: Mapping the Future of Parkinson’s Disease
This national initiative offers genetic testing for clinically relevant Parkinson's-related genes and genetic counseling at no cost for people with Parkinson’s. Participation can be either in-person or from home.
Parkinson’s Foundation Surveys
Through this initiative, we aim to advance Parkinson’s care through understanding the experiences of people living with this disease, care partners and healthcare workers —and widely sharing those experiences with the PD community.
People with Parkinson's have a higher risk of fractures. Help us find a solution. The TOPAZ study will test if a medicine called zoledronate can prevent fractures in people with PD. A team of doctors who are experts in bone health and PD are leading the study.
The ATLANTIS Study is testing a once-daily oral investigational drug called UCB0022 in people between 35 and 80 who have been diagnosed with Parkinson’s 5 or more years ago and whose motor symptoms change significantly over the course of the day.
Become a Research Advocate
Help us make Parkinson’s research more efficient and effective. Our trained research advocates partner alongside scientists, industry and government on critical PD research studies.
Trials for People with Genetic Links to PD
Explore precision medicine trials designed for people with a confirmed genetic link to Parkinson’s, as tested in the PD GENEration study.
Note that we will constantly update this list as new trials testing medications for people with genetic forms of PD are announced. If you have information about a new trial, please email Genetics@Parkinson.org.
ClinicalTrials.gov contains a complete list of PD-related trials.
There are currently no trials recruiting participants with mutations of the following PD-related genes: SNCA, PRKN, PINK1, PARK7 or PS35.
Join the Fight Against Parkinson's
Support ground-breaking research, care and community outreach